Login / Signup

Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results.

Sadettin UsluSemih GulleÖzkan UrakGercek SenHüseyin Ediz DalkılıçAbdurrahman Soner ŞenelServet AkarGüzide Nevsun İnançAyşe CefleAydan Köken AvşarServet YolbasSema YilmazOzgül Soysal Gündüzİsmail SariAhmet Merih BirlikNurullah AkkocFatoş Önen
Published in: Archives of rheumatology (2024)
Research in the TURKBIO cohort reveals that both older and younger patients with AS exhibited similar disease activity levels with comparable treatment approaches. Moreover, the results of TNFi treatments in elderly patients were the same as those observed in younger patients, with no notable increase in safety concerns.
Keyphrases
  • ankylosing spondylitis
  • disease activity
  • rheumatoid arthritis
  • systemic lupus erythematosus
  • middle aged
  • rheumatoid arthritis patients
  • electronic health record
  • machine learning
  • data analysis
  • smoking cessation